Mark V. Rubertone

4.8k total citations · 1 hit paper
39 papers, 3.4k citations indexed

About

Mark V. Rubertone is a scholar working on Surgery, Molecular Biology and Rheumatology. According to data from OpenAlex, Mark V. Rubertone has authored 39 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Molecular Biology and 7 papers in Rheumatology. Recurrent topics in Mark V. Rubertone's work include Testicular diseases and treatments (13 papers), Sexual Differentiation and Disorders (9 papers) and Sperm and Testicular Function (7 papers). Mark V. Rubertone is often cited by papers focused on Testicular diseases and treatments (13 papers), Sexual Differentiation and Disorders (9 papers) and Sperm and Testicular Function (7 papers). Mark V. Rubertone collaborates with scholars based in United States and Canada. Mark V. Rubertone's co-authors include Judith A. James, Melissa R. Arbuckle, John B. Harley, G. Dennis, Micah T. McClain, R. Hal Scofield, John F. Brundage, Katherine A. McGlynn, Barry I. Graubard and Ralph L. Erickson and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Mark V. Rubertone

39 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

2003 1.8k citations Melissa R. Arbuckle, Mark V. Rubertone et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark V. Rubertone United States	22	1.7k	1.3k	770	484	406	39	3.4k
Luis M. Vilá Puerto Rico	36	3.3k 1.9×	2.0k 1.6×	560 0.7×	298 0.6×	596 1.5×	148	4.3k
Thomas J A Lehman United States	35	1.6k 0.9×	1.1k 0.8×	297 0.4×	648 1.3×	419 1.0×	106	4.2k
Dae‐Hyun Yoo South Korea	35	2.2k 1.3×	2.8k 2.2×	464 0.6×	618 1.3×	365 0.9×	198	5.3k
Alexis Mathian France	41	2.3k 1.3×	3.2k 2.4×	467 0.6×	464 1.0×	522 1.3×	135	5.9k
René‐Marc Flipo France	38	2.8k 1.6×	674 0.5×	260 0.3×	369 0.8×	559 1.4×	212	4.7k
Michele F. Doran Ireland	21	2.4k 1.4×	824 0.6×	261 0.3×	169 0.3×	405 1.0×	33	3.7k
José Luís Andreu Spain	27	960 0.6×	695 0.5×	347 0.5×	176 0.4×	192 0.5×	177	2.6k
Reiji Kasukawa Japan	29	1.0k 0.6×	1.4k 1.1×	218 0.3×	703 1.5×	409 1.0×	215	4.3k
Elena Massarotti United States	22	1.0k 0.6×	790 0.6×	252 0.3×	608 1.3×	193 0.5×	38	2.6k
M.V. Hernández Spain	33	1.5k 0.9×	672 0.5×	229 0.3×	454 0.9×	195 0.5×	113	2.9k

Countries citing papers authored by Mark V. Rubertone

Since Specialization

Citations

This map shows the geographic impact of Mark V. Rubertone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark V. Rubertone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark V. Rubertone more than expected).

Fields of papers citing papers by Mark V. Rubertone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark V. Rubertone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark V. Rubertone. The network helps show where Mark V. Rubertone may publish in the future.

Co-authorship network of co-authors of Mark V. Rubertone

This figure shows the co-authorship network connecting the top 25 collaborators of Mark V. Rubertone. A scholar is included among the top collaborators of Mark V. Rubertone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark V. Rubertone. Mark V. Rubertone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rubertone, Mark V., et al.. (2015). Description and Utilization of the United States Department of Defense Serum Repository: A Review of Published Studies, 1985-2012. PLoS ONE. 10(2). e0114857–e0114857. 37 indexed citations

Levin, Lynn I., Ellen T. Chang, Richard F. Ambinder, et al.. (2012). Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma. Blood. 120(18). 3750–3755. 33 indexed citations

Chia, Victoria M., Yan Li, Sabah M. Quraishi, et al.. (2009). Effect modification of endocrine disruptors and testicular germ cell tumour risk by hormone‐metabolizing genes. International Journal of Andrology. 33(4). 588–596. 29 indexed citations

Chia, Victoria M., Yan Li, Lynn R. Goldin, et al.. (2008). Risk of cancer in first‐ and second‐degree relatives of testicular germ cell tumor cases and controls. International Journal of Cancer. 124(4). 952–957. 14 indexed citations

McGlynn, Katherine A., Sabah M. Quraishi, Barry I. Graubard, et al.. (2008). Persistent Organochlorine Pesticides and Risk of Testicular Germ Cell Tumors. JNCI Journal of the National Cancer Institute. 100(9). 663–671. 142 indexed citations

Cook, Michael B., Barry I. Graubard, Sabah M. Quraishi, et al.. (2008). Genetic variants in the 8q24 locus and risk of testicular germ cell tumors. Human Genetics. 123(4). 409–418. 7 indexed citations

Chia, Victoria M., Sabah M. Quraishi, B. I. Graubard, et al.. (2008). Insulin-like Growth Factor 1, Insulin-like Growth Factor-Binding Protein 3, and Testicular Germ-Cell Tumor Risk. American Journal of Epidemiology. 167(12). 1438–1445. 7 indexed citations

Cook, Michael B., Barry I. Graubard, Mark V. Rubertone, Ralph L. Erickson, & Katherine A. McGlynn. (2008). Perinatal factors and the risk of testicular germ cell tumors. International Journal of Cancer. 122(11). 2600–2606. 45 indexed citations

Figueroa, Jonine D., Lori C. Sakoda, Barry I. Graubard, et al.. (2008). Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors. Cancer Causes & Control. 19(9). 917–929. 29 indexed citations

10.

Schneerson, Rachel, et al.. (2008). Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel. Vaccine. 26(7). 869–873. 14 indexed citations

11.

Hsu, Lucy L., Remington L. Nevin, Steven K. Tobler, & Mark V. Rubertone. (2007). Trends in Overweight and Obesity Among 18-Year-Old Applicants to the United States Military, 1993–2006. Journal of Adolescent Health. 41(6). 610–612. 44 indexed citations

12.

Cook, Michael B., Yuanyuan Zhang, Barry I. Graubard, et al.. (2007). Risk of testicular germ-cell tumours in relation to childhood physical activity. British Journal of Cancer. 98(1). 174–178. 10 indexed citations

13.

Majka, Darcy S., Kevin D. Deane, Lezlie A. Parrish, et al.. (2007). Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Annals of the Rheumatic Diseases. 67(6). 801–807. 146 indexed citations

14.

Brundage, John F., Karen E. Johnson, Jeffrey L. Lange, & Mark V. Rubertone. (2006). Comparing the Population Health Impacts of Medical Conditions Using Routinely Collected Health Care Utilization Data: Nature and Sources of Variability. Military Medicine. 171(10). 937–942. 13 indexed citations

15.

McGlynn, Katherine A., Lori C. Sakoda, Mark V. Rubertone, et al.. (2006). Body Size, Dairy Consumption, Puberty, and Risk of Testicular Germ Cell Tumors. American Journal of Epidemiology. 165(4). 355–363. 50 indexed citations

16.

Wasserman, Glenn M., et al.. (2003). Analysis of Adverse Events after Anthrax Immunization in US Army Medical Personnel. Journal of Occupational and Environmental Medicine. 45(3). 222–233. 47 indexed citations

17.

Lange, Jeffrey L., et al.. (2003). Comprehensive systematic surveillance for adverse effects of Anthrax Vaccine Adsorbed, US Armed Forces, 1998–2000. Vaccine. 21(15). 1620–1628. 36 indexed citations

18.

Arbuckle, Melissa R., Judith A. James, Kimmie F. Kohlhase, et al.. (2001). Development of Anti‐dsDNA Autoantibodies Prior to Clinical Diagnosis of Systemic Lupus Erythematosus. Scandinavian Journal of Immunology. 54(1-2). 211–219. 96 indexed citations

19.

Richards, Alexsia, et al.. (2001). Serosurvey of Borrelia burgdorferi infection among U.S. military personnel: a low risk of infection.. American Journal of Tropical Medicine and Hygiene. 65(6). 804–809. 5 indexed citations

20.

Preston, D M, Lynn I. Levin, Debra J. Jacobson, et al.. (2000). Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology. 56(5). 812–816. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact